Covidien European launch for brain aneurysm device; Consano Medical gets Series A;

@FierceMedDev: Check out our newest special report: Top 10 med tech R&D budgets. Read | Follow @FierceMedDev

@StacyALawrence: Newly public Inogen gains on FDA clearance for home oxygen device. Story | Follow @StacyALawrence

@MichaelGFierce: Intersect ENT files for $80M IPO to support steroid-delivering sinus implants. More via FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: Ultrasound therapy outfit rakes in $2M for wearable chronic pain device. Story | Follow @EmilyWFierce

> Europe will see the release of a new device from Covidien ($COV), Pipeline Flex embolization, for unruptured brain aneurysms. The new technology is designed for easy deployment without unnecessarily taking up space. Story

> Consano Medical, a medical device company that split off from medical device incubator TheraNova, closed a Series A funding round at $3.9 million, thanks to the targeted investor technology of Deals Lab, an online financing platform. Release

> FDA has issued a Global Unique Device Identification Database (GUDID) guidance to explain how the database is to be used in connection with the Unique Device Identification (UDI) system. Full guidance

Biotech News

@FierceBiotech: Polaris preps for a $400M fund to back a new wave of biotechs. More | Follow @FierceBiotech

@JohnCFierce: Biotech vets target $43M round to debut new antifungal venture. Story | Follow @JohnCFierce

@DamianFierce: We need to commission an inversion graphic for future stories. Article | Follow @DamianFierce

@EmilyMFierce: Gives a new meaning to YOLO: The Higgs Boson should have crushed the universe. More | Follow @EmilyMFierce

> Boehringer bags a 'breakthrough' tag for its Pradaxa antidote. Story

> Auxilium eyes a Canadian biotech for a tax-cutting merger. More

> FDA experts spurn AstraZeneca's pitch for ovarian cancer drug olaparib. Article

Pharma News

@FiercePharma: Special: The top 5 vaccines by 2020. Report | Follow @FiercePharma

@TracyStaton: Here's @JohnCFierce's take on the Vertex VX-809/Kalydeco PhIII, including interview with CEO Jeff Leiden. Story | Follow @TracyStaton

@EricPFierce: Actavis says growing production at plant in Malta called for new warehouse. More | Follow @EricPFierce

@CarlyHFierce: Here's this week's issue of FierceVaccines. Hint: It's a good one. Issue | Follow @CarlyHFierce

> Eli Lilly's anti-takeover superpower? A shield forged by Indiana lawmakers. Story

> Biogen MS blockbuster Tecfidera earns high marks for safety. Article

> Reuters: Valeant supporter Paulson grabs 6 million-plus Allergan shares. More

> After 4-year Benicar review, FDA slaps aside heart-risk worries. News

Vaccines News

> Italian officials probe Novartis for possible flu vaccine pricing fraud. Story

> FDA slaps Glaxo with warning letter for FluLaval plant. More

> CDC committee recommends AZ's FluMist over flu shot in children. Article

> The top 5 vaccines by 2020. Report

> Feds charge researcher in HIV vaccine fraud case. More

> Reuters: Sanofi plans to put dengue program into separate unit. News

Pharma Manufacturing News

> FDA finds contamination issues at GSK vax plant. More

> India production expert urges excellence from drugmakers. Story

> New Indian government looks to help small players finance upgrades. Article

> Sanofi buys Dubai's Globalpharma to produce generics in the Middle East. News

> Actavis opens $18M warehouse on Malta. Report

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.